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Summary
Although the multifactorial nature of osteoarthritis (OA) is well recognized, genetic factors have been found to be strong determinants of the
disease. Evidence of a genetic influence of OA comes from a number of sources, including epidemiological studies of family history and
family clustering, twin studies, and exploration of rare genetic disorders. Classic twin studies have shown that the influence of genetic factors
is between 39% and 65% in radiographic OA of the hand and knee in women, about 60% in OA of the hip, and about 70% in OA of the spine.
Taken together, these estimates suggest a heritability of OA of 50% or more, indicating that half the variation in susceptibility to disease in
the population is explained by genetic factors. Studies have implicated linkages to OA on chromosomes 2q, 9q, 11q, and 16p, among others.
Genes implicated in association studies include VDR, AGC1, IGF-1, ER alpha, TGF beta, CRTM (cartilage matrix protein), CRTL (cartilage
link protein), and collagen II, IX, and XI. Genes may operate differently in the two sexes, at different body sites, and on different disease
features within body sites. OA is a complex disease, and understanding its complexity should help us find the genes and new pathways and
drug targets.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Evidence of a genetic influence in osteoarthritis
This paper presents a brief overview of the genetics of
osteoarthritis (OA) and its relationship to bone and bone
density. Although the multifactorial nature of OA is well
recognized, genetic factors have been found to be
strong determinants of this disease. Evidence of a genetic
influence of OA comes from a number of sources, includ-
ing epidemiological studies of family history and family
clustering, adoption studies, twin studies, and explora-
tion of rare genetic disorders related to OA, such as
chondrodysplasias.
FAMILY STUDIES
Family studies provide an indication of the extent to
which the external environment and the genetically-
determined internal environment account for disease.
Familial clustering of OA has been recognized since the
earliest descriptions of the disease; however, its impor-
tance in terms of etiology has only recently been fully
appreciated. Familial clustering of Heberden’s nodes of
the fingers was first formally studied by Stecher in the
1940s1. Family clustering of hand and knee OA has since
been confirmed in epidemiological surveys in the U.K. by
Kellgren et al.2. and more recently in large community-
based surveys in the U.S., such as the Baltimore Longi-
tudinal Study of Aging3 and the Framingham Offspring
Study4.
Clustering of hip OA has been more difficult to study
because of its low prevalence. The recently published
community-based surveys have not included data on
radiographic hip OA3,4. Nevertheless, studies designed to
evaluate the prevalence of disease among siblings of
probands who have undergone total joint replacement have
shown 2- to 3-fold increases in the risk of OA relative to
controls5–8. The 4.7-fold increase in risk observed in the
study by Lanyon et al.7. is probably a slight overestimate
resulting from the methods used for case selection.
These studies show that within affected families there is
a clustering of cases of OA in the hands, knees, and hip,
with significant increases in risk among relatives of
probands. Evidence of family clustering of OA of the spine
has also been presented in several radiological case re-
ports and case series of sciatica9, cervical spondylosis10,
and herniated discs11–13.
Only limited information is available from family studies,
in part because little family history data have been col-
lected, and in part because data gathered by questioning
patients with OA about their parents has been considered
unreliable. Further, family studies have a number of short-
comings that restrict their interpretation. Chief among these
is the failure to ensure that index individuals and relatives
are matched with respect to age. Age matching is particu-
larly important in diseases such as OA in which age has a
crucial effect on the disease. In addition, family studies do
not permit differentiation of clustering that is due to a
shared environment from clustering that is caused by
genetic factors. For example, environmental factors, such
as patterns of exercise, that may affect the risk of OA have
been shown to cluster in families and are difficult to control
for in epidemiological studies. Furthermore, population
data on hip and spine OA are limited, making it difficult to
determine the expected rates of OA at these sites for
comparative purposes.
1 Supported by Procter & Gamble Pharmaceuticals, Mason, OH
*Address correspondence to: Tim D. Spector, MD, Twin
Research & Genetic Epidemiology Unit, St. Thomas’ Hospital,
London, SE1 7EH, UK. Tel.: +44-207-960-5557; Fax: +44-207-
922-8234; E-mail: tim.spector@kcl.ac.uk
E-mail: http://www.twin-research.ac.uk
International
Cartilage
Repair
Society
S39
OsteoArthritis and Cartilage (2004) 12, S39–S44
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.joca.2003.09.005
TWIN STUDIES
Clustering of disease in families is due either to shared
genetic influences or the shared family environment. The
study of twins, specifically the comparison of the occur-
rence of disease in monozygotic (MZ) and dizygotic (DZ)
twins, allows the effects of genetic factors and the shared
family environment to be separated in a design that natu-
rally allows matching for age. Because MZ twins have
identical genes, any intrapair variation may be attributed to
environmental factors. In contrast, DZ twins share, on
average, only half of their genes, and any intrapair differ-
ences may be attributed to both environmental and genetic
factors. Comparison of the occurrence of disease in MZ
and DZ twins, therefore, makes it possible to quantify
genetic and environmental contributions to disease and
disease-related traits in a population14. Classic twin studies
can yield a good estimate of the heritability, defined as
the relative contribution of genetic variance to the liability
to disease, of any disease in a population15. Using an
MZ-discordant design (one affected co-twin) also permits
ideally matched case-control studies to be performed.
In the last 10 years, we have been collecting data relating
to OA from a large group of healthy twins that make up the St.
Thomas’ UK Adult Twin Registry16. The registry is a volunteer-
based group of nearly 10 000 adult, mainly female, twin pairs
recruited through media campaigns from the healthy UK
population. These volunteers are representative of the UK
population in terms of most environmental risk factors, rates
of OA, and disease features and have been found to be
similar to the Chingford population of age-matched singletons
for a range of musculoskeletal phenotypes17.
We first assessed the relative contribution of genetic and
environmental factors to OA of the hands and knees in
130 MZ and 120 DZ female twins aged 48 to 70 years in a
classic twin study18. The correlations of radiographic osteo-
phytes and joint space narrowing at most sites and the
presence of Heberden’s nodes and knee pain were higher
in the MZ pairs than in the DZ pairs. The findings from this
study showed that the influence of genetic factors in
radiographic OA of the hand and knee in women is between
39% and 65%, independent of known environmental or
demographic confounding factors. In another study in a
larger sample of twins, we found that joint space narrowing
of the hip was also heritable, with an estimated heritability
of 60%19. We also evaluated the extent of genetic influ-
ences on disc degeneration in 172 MZ and 154 DZ twins
unselected for back pain or disc disease20 using magnetic
resonance images of the cervical and lumbar spine. For
the overall degeneration score, heritability was 73% at the
cervical spine and 74% at the lumbar spine.
Interestingly, when we examined the genetic contribution
to the various individual features of OA, we found differ-
ences in genetic influence. The data on disc height and disk
bulge suggested a strong genetic component, whereas
disc signal intensity did not differ between the MZ and DZ
pairs, suggesting that environmental factors are the pre-
dominant influence affecting this measure. These findings
may provide insight into which clinical findings are actually
part of OA and which are not, since it is unlikely that
some aspects of the disease are genetic while others
are not.
Our findings indicate that OA of the spine, hip, knee, and
hand are all heritable to slightly different extents (Fig. 1).
Taken together, these heritability estimates suggest that at
least half the variation in susceptibility to disease in the
population is explained by genetic factors.
Candidate genes in the inheritance of
osteoarthritis
The findings that OA is a largely heritable disease raise
the question of which genes are responsible. Clues come
from studies of inherited diseases in which OA forms a part
and for which single-gene defects have been identified,
such as chondrodysplasias, spondyloepiphyseal dysplasia,
and collagen II and IX mutations21,22; from animal models
of inherited skeletal disorders23; and from rare examples
of familial OA, which have tended to implicate genes for
collagen and other structural proteins24–28. Although some
studies have shown the presence of mutations in the
COL2A1 gene for type II procollagen in individuals affected
with OA in some families26,29, other studies have indicated
that this gene is not the disease locus in other families with
common OA29,30. These strictly familial diseases are rare,
and the small number of family studies do not allow
conclusions to be drawn regarding the contribution of
genetics to disease in the population. In fact, there is
currently little evidence that common forms of OA are due
to mutations in genes for collagen31.
From the results of segregation analyses of data from the
Framingham Offspring Study, which are now sufficiently
mature that the offspring of the original cohort have devel-
oped disease, Felson et al.4. inferred that there is significant
genetic contribution to hand and knee OA, with a pattern
most consistent with that of a major Mendelian gene and a
multifactorial component. This multifactorial component
may be other genes or environmental or personal factors32.
However, as with most segregation analyses, other
explanations and interpretations are possible33.
Linkage studies have implicated quantitative trait loci
(QTL) regions on chromosomes 2q, 9q, 11q, and 16p,
among others (Table I)34–38. Candidate genes for OA on
these chromosomes include those encoding for fibronectin,
a glycoprotein present in the extracellular matrix of normal
cartilage; the alpha-2 chain of collagen type V, a major
constituent of bone; the interleukin 8 receptor, important in
the regulation of neutrophil activation and chemotaxis,
within the 2q23-25 region of chromosome 2;14 and the
so-called “high bone mass locus” and the matrix metallo-
proteinase (MMP) gene cluster on chromosome 11q40. The
conclusions reached on the basis of these studies are
limited by the small size and relatively small logarithm of
the odds (Lod) scores of the studies. Loughlin et al.
Fig. 1. Estimated heritability of osteoarthritis at different sites.
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conducted linkage analyses in a larger study including 481
families that each contained at least one pair of siblings
who had undergone knee or hip joint replacements35,39–41.
This study included men and women and mixed-sex sib-
lingships, and combined data from patients with hip and
knee OA. As a consequence, this study did not at first
reveal any meaningful information. When the data were
subdivided by sex and site of OA, clearer patterns began to
emerge, particularly in the female hip OA group, in which a
linkage of the type IX collagen gene COL9A1 (6q12-q13) to
OA was suggested39. Findings from a recent study from the
Framingham group revealed a large number of suggestive
linkages to hand OA score in around 300 unselected
families38. The heritabilities determined in this study were
lower than previously found. Unfortunately, none of these
linkages clearly coincided with those areas previously
reported, including the area on chromosome 2 most
commonly linked with OA. Moreover a large linkage study
using fine mapping failed to find any significant at 2q for
hand or knee42.
Genes implicated in association studies to date are seen
in Table II43,47. The most consistent finding is that of the
involvement of the VDR gene44,45, but this has not been
replicated in family candidate linkage studies31,46. One
would anticipate that this list will grow, and that as analyses
are repeated in larger samples and different populations,
inconsistencies will become fewer. Interestingly, the list of
genes associated with osteoporosis is virtually the same as
that for OA, with the exception of those for cartilage. The
results of these association studies, even of the best
candidate, VDR, are still uncertain and remain to be con-
firmed in larger studies in more homogeneous populations.
Genetic influences in symptomatic osteoarthritis
Radiographs provide no information on pain or disability,
and it is well known that the overlap between pain and
radiological change is inexact. For example, abnormal
findings on magnetic resonance images of the lumbar
spine do not necessarily correlate with clinical symptoms47.
Symptomatic OA and radiographic OA may well represent
two different although related phenotypes with different
underlying causes involving different genes. Studies have
so far not been large enough to explore both.
Clustering and specificity of disease features
One has to be aware also that genes may operate
differently in the two sexes, at different body sites, and on
different disease features within body sites. Heritability
appears to be greater in females41,48. Site-specificity of
genetic effects has been suggested in recent linkage re-
sults41, and association studies have implicated different
genes (e.g., VDR and COL2A1) in the occurrence of
osteophytosis and joint space loss49. Therefore, certain
genes may ‘turn on’ bone but not cartilage, so each tissue
must be examined separately to allow accurate determi-
nation of genetic linkages. Combining all individuals with
OA without regard to whether they are ‘bone formers’ or
‘cartilage losers’ may make it impossible to detect a tissue-
specific effect. Clearly, studies will provide more information
if they are designed to examine populations representing
specific aspects or different components of OA.
The relationship between osteoarthritis and
osteoporosis
The question remains, are the genes for bone density
and OA pleiotropic (shared)? Studies have shown that
there is a difference of 6% to 8% in bone mineral density
(BMD) between populations of subjects with OA and con-
trols50,51. Twin studies, which allow adjustment and match-
ing for genetic factors, have shown that MZ twins
discordant for OA demonstrate discordance in BMD of the
hip of only 3% to 4%52. The difference in the discordance of
6% to 8% at the population level and 3% to 4% in MZ twins
suggests that some genes overlap both phenotypes52.
The heritability of different osteoporosis-related pheno-
types that are important independent risk factors is gener-
ally about 50% or greater. Heritability is close to 80% for
spinal BMD and over 60% for muscle mass53, both of which
are important determinants in OA and osteoporosis. Hip
axis length, a measure of the size of the femur, is also
heritable, as is broadband ultrasound attenuation and vel-
ocity of sound of the calcaneus, a measure of bone
structure not yet fully understood54. About 75% of the
variability observed in urinary collagen crosslinks (markers
of bone resorption) is due to genes55. These markers are
also elevated in OA56,57. These findings suggest that most
of the variation in susceptibility to osteoporosis in the
population is best explained by genetic causes. Modifying
these genes could be important for both diseases.
Table I
Major chromosomal regions with linkages to osteoarthritis (OA)
Chromosome Reference
2q23-35 (nodal OA) Wright, 199634
2q12-14 (DIP* OA) Leppavuori et al.36
2q31-32, 4q 12-21, 6p/6q, 16p, Col 9A1 (THR†) Loughlin et al.35; Mustafa et al.39
4q27, Xp11.3, 7p22 (DIP* OA) Leppavuori et al.36
16p (hip OA) Ingvarsson et al.37
1p, 17,9,13,19 (hand OA scores) Demissie et al.38
*DIP=distal interphalangeal joint.
†THR=total hip replacment.
Table II
Genes implicated in osteoarthritis in association studies
VDR CRTM (cartilage matrix protein)
Col2A CRTL (cartilage link protein)
AGC1 A1ACT
IGF-1 COL9A1
ER alpha COL11A1
TGF beta COl1A1
ANK
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Conclusions
In conclusion, the epidemiological study of OA has
allowed us to quantify the disease burden and the contri-
bution of genetic and environmental risks in populations. It
also allows us to quantify the importance of individual risk
factors operating as potential targets for disease prevention
and reveals disease mechanisms as targets for drug inter-
vention. Genes are the strongest risk factor for OA in the
general population. Fig. 2 schematically shows a simplistic
picture of the role of genes in OA. Genes act through a
complex web of mechanisms involving injury and its avoid-
ance; response to injury; body weight; muscle mass; and
bone structure and bone turnover or cartilage structure
and cartilage turnover or, synergistically, the two together.
Clearly the heritability of OA is very complex, and under-
standing its complexity should help us find the genes and
new pathways and drug targets. To better understand the
genetic component of OA in the future, larger linkage
studies are needed that focus more attention on pheno-
type, sex, and disease site. Better and larger association
studies are needed that are adequately powered and
use greater numbers of genetic markers, such as either
anonymous single nucleotide polymorphisms (SNPs) or
specified candidates. Other techniques to increase power
and reduce cost include using DNA pooling and extreme
discordants, along with parallel animal studies (e.g., the
study on the ANK gene58). Clinical and genetic programs
incorporating study of both OA and osteoporosis will also
provide extra power to find the genes for both disorders as
well as new pathways.
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